Research Study

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Principal Investigator 
Brian Toyota

Overview

Body Locations and Systems 
Tumour
ClinicalTrials.gov# 
NCT02392078
Status 
Recruiting
Study Start/End 
Feb 29, 2016 to Dec 1, 2017
Locations 
Vancouver General Hospital
Name/Title 
Camille Hunt, Clinical Research Coordinator
Phone 
604-875-4111 ext.61505
Email Address 
camille.hunt@ubc.ca
Purpose of Study 

The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in April 2013, the NBS has been used in over 300 procedures conducted at approximately 20 leading institutions across United States. This is a prospective, multi-center registry that will include data collection up to 12 months to evaluate procedural success, local control failure rate, and QoL in up to 1,000 patients and up to 50 sites.
 

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.